Literature DB >> 2160142

Collagenase-induced intracerebral hemorrhage in rats.

G A Rosenberg1, S Mun-Bryce, M Wesley, M Kornfeld.   

Abstract

Intracranial bleeding is an important cause of brain masses and edema. To study the pathophysiology of intracerebral hemorrhage, we produced experimental hemorrhages in 53 rats and characterized the lesion by histology, brain water content, and behavior. Adult rats had 2 microliters saline containing 0.5 unit bacterial collagenase infused into the left caudate nucleus. Histologically, erythrocytes were seen around blood vessels at the needle puncture site within the first hour. By 4 hours there were hematomas, the size of which depended on the amount of collagenase injected. Necrotic masses containing fluid, blood cells, and fibrin were seen at 24 hours. Lipid-filled macrophages were observed at 7 days and cysts at 3 weeks. Water content was significantly increased 4, 24, and 48 hours after infusion at the needle puncture site and for 24 hours in posterior brain sections. Behavioral abnormalities were present for 48 hours, with recovery of function occurring during the first week. Brain tissue contains Type IV collagen in the basal lamina. Collagenase, which occurs in an inactive form in cells, is released and activated during injury, leading to disruption of the extracellular matrix. Collagenase-induced intracerebral hemorrhage is a reproducible animal model for the study of the effects of the hematoma and brain edema.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160142     DOI: 10.1161/01.str.21.5.801

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  180 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

3.  Fibroblast growth factors preserve blood-brain barrier integrity through RhoA inhibition after intracerebral hemorrhage in mice.

Authors:  Bin Huang; Paul R Krafft; Qingyi Ma; William B Rolland; Basak Caner; Tim Lekic; Anatol Manaenko; Mai Le; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

4.  Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.

Authors:  Jayalakshmi Caliaperumal; Shannon Wowk; Sarah Jones; Yonglie Ma; Frederick Colbourne
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

5.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

6.  Elevated blood pressure causes larger hematoma in a rat model of intracerebral hemorrhage.

Authors:  Prerana M Bhatia; Ryan Chamberlain; Xianghua Luo; Eliza W Hartley; Afshin A Divani
Journal:  Transl Stroke Res       Date:  2012-07-25       Impact factor: 6.829

7.  Do current animal models of intracerebral hemorrhage mirror the human pathology?

Authors:  Opeolu Adeoye; Joseph F Clark; Pooja Khatri; Kenneth R Wagner; Mario Zuccarello; Gail J Pyne-Geithman
Journal:  Transl Stroke Res       Date:  2010-08-10       Impact factor: 6.829

Review 8.  Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery.

Authors:  Balachandar Kathirvelu; S Thomas Carmichael
Journal:  Metab Brain Dis       Date:  2014-05-10       Impact factor: 3.584

Review 9.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 10.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.